MFAP5 is associated with poor prognosis in cancers like ovarian and intrahepatic cholangiocarcinoma, and high MFAP5 expression in CAFs correlates with unfavorable outcomes in pancreatic cancer [66,67]. Here, MFAP5 is linked to familial pancreatic carcinoma.